• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES AORTIC TAG THORACIC ENDOPROSTHESIS (CTAG WITH ACTIVE CONTROL); SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES AORTIC TAG THORACIC ENDOPROSTHESIS (CTAG WITH ACTIVE CONTROL); SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Catalog Number TGMR373720E
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Infarction, Cerebral (1771)
Event Date 11/05/2019
Event Type  Injury  
Manufacturer Narrative
Additional medical device involved in this event: gore® tag® conformable thoracic stent grafts with active control system tgm454515e/20757723.Udi for this device: (b)(4).(b)(4).
 
Event Description
The following information was reported to gore: on (b)(6) 2019, this patient underwent endovascular treatment for a thoracic aortic aneurysm and was treated with two gore® tag® conformable thoracic stent grafts with active control system.Prior to the implant, a carotid-subclavian bypass involving both carotid arteries was performed to create a landing zone for the endoprostheses.On procedure day in the evening, the patient was reported to have suffered middle cerebral artery ischemia, necessitating re-intubation on the intensive care unit.According to the physician, the stroke was secondary to the surgery and considered unrelated to the implant.
 
Manufacturer Narrative
H6, code 22: according to the gore® tag® conformable thoracic stent graft instructions for use (ifu), adverse events which may require intervention and/or conversion to open repair include, but are not limited to: cerebrovascular accident.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AORTIC TAG THORACIC ENDOPROSTHESIS (CTAG WITH ACTIVE CONTROL)
Type of Device
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
MDR Report Key9407851
MDR Text Key182965261
Report Number2017233-2019-01208
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
PMA/PMN Number
P040043
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup
Report Date 03/03/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date02/11/2022
Device Catalogue NumberTGMR373720E
Device Lot Number20697755
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Initial Date Manufacturer Received Not provided
Initial Date FDA Received12/04/2019
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received03/03/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age65 YR
Patient Weight90
-
-